Awarded
Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.
Descriptions
The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.
Timeline
Published Date :
Deadline :
Tender Awarded :
Awarded date :
Contract Start :
Contract End :
Tender Regions
CPV Codes
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors